Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Genetic Risk for Attention Deficit Hyperactivity Disorder Expressed in Brain Functioning

NCT00143832 is registered in ClinicalTrials.gov with UMC Utrecht as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00143832 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Genetic Risk for Attention Deficit Hyperactivity Disorder Expressed in Brain Functioning
Lead sponsor
UMC Utrecht
Phase
Observational
Overall status
Unknown status
Start date
September 30, 2004
Completion date
Not reported
Enrollment
90
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

attention deficit hyperactivity disorder